| MEDNAX, Inc. | Key Financials | Relative to Peer Avg |
|---|---|---|
| Quarterly Revenue Growth | 18.95% | |
| Annual Revenue Growth | 43.98% | |
| Quarterly Net Income Growth | 14.51% | |
| Annual Net Income Growth | 37.72% | |
| Quarterly Free Cash Flow Growth | ||
| Total Debt Relative to Total Capital | 8.05% | |
| Operating Margin | 18.21% | |
| Return on Equity | 11.774% |
| MEDNAX, Inc. (MD) Dilution Analysis | |||
|---|---|---|---|
| Latest EPS | $1.1 | -$0.02 | |
| Company | Revenue* | Net Income* | Rating | Sentiment |
|---|---|---|---|---|
| FMS | 3,527.54 | 229.64 | Sign up to view | |
| DVA | 2,829.58 | 16.79 | Sign up to view | |
| MD | 502.72 | 55.37 | Sign up to view | |
| PMC | 439.80 | 10.50 | Sign up to view | |
| WOOF | 438.61 | 30.48 | Sign up to view | |
| GTIV | 415.59 | -207.18 | Sign up to view | |
| CHE | 366.64 | 22.28 | Sign up to view | |
| AMED | 339.18 | 2.68 | Sign up to view | |
| HGR | 233.54 | 9.49 | Sign up to view | |
| ENSG | 218.20 | -12.15 | Sign up to view | |